VivoSeq
Other

Systemic Inflammation

1

Pipeline Programs↗

5

Active Trials↗

1

Companies Involved↗

Systemic Inflammation is an early-stage landscape with 1 program across 1 company. The most active players are Nutraland USA, Inc..

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Nutraland USA, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

IV Immunoglobulin

National Institute of Neurological Disorders and Stroke (NINDS)

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

15

clinical trials

Completed7 · 47%
Recruiting3 · 20%
Terminated2 · 13%
Unknown status1 · 7%
Enrolling by invitation1 · 7%
Not yet recruiting1 · 7%

Clinical Trials

Trial Activity

15 trials

Reducing Systemic Inflammation in People on Antiretroviral Therapy
Recruiting·—·Phase 2·NCT07030920·150 enrolled
Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
Recruiting·AAlloksys Life Sciences B.V.·Phase 2/3·NCT03050476·1,250 enrolled
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
Recruiting·IIcahn School of Medicine at Mount Sinai·Phase 1·NCT07058974·22 enrolled
A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Anti-Inflammatory and Healthy Aging Effects of AppleX™ Apple Extract (15% Fisetin) in Adults 45-70 Years of Age
Not yet recruiting·NNutraland USA, Inc.·Preclinical·NCT07678346·70 enrolled
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (IN-PASC)
Enrolling by invitation·National Institute of Neurological Disorders and Stroke (NINDS)·Phase 2·NCT05350774·45 enrolled
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
Completed·AA.O.U. Città della Salute e della Scienza·Phase 2/3·NCT03577249·45 enrolled
Inhaled Steroid Reduces Systemic Inflammation in COPD
Completed·UUniversity of British Columbia·Phase 4·NCT00175565·50 enrolled
Pentoxifylline and Systemic Inflammation in Hemodialysis Patients
Completed·CCoordinación de Investigación en Salud, Mexico·Phase 4·NCT01269827·36 enrolled
Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD
Completed·—·Phase 4·NCT02209974·23 enrolled
Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT02844621·25 enrolled
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
Completed·—·Phase 3·NCT03229538·1,263 enrolled
Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons (COVID ARC 19)
Completed·National Institutes of Health Clinical Center (CC)·N/A·NCT04401449·202 enrolled
Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty
Terminated·GG. d'Annunzio University·Phase 3·NCT02205775·280 enrolled
Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture
Terminated·UUMC Utrecht·Phase 3·NCT01275976·11 enrolled
Metformin and Systemic Inflammation in HIV
Unknown status·HHospital Civil de Guadalajara·Phase 4·NCT03774108·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)